(Q53065079)

English

Incidence for progression of hypervascular HCC in hypovascular hepatic nodules showing hyperintensity on gadoxetic acid-enhanced hepatobiliary phase in patients with chronic liver diseases.

scientific article published on 24 May 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24854900

Incidence for progression of hypervascular HCC in hypovascular hepatic nodules showing hyperintensity on gadoxetic acid-enhanced hepatobiliary phase in patients with chronic liver diseases. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24854900

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

chronic liver disease

0 references

author name string

Megumi Matsuda

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24854900

Takaharu Tsuda

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24854900

Shinji Yoshioka

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24854900

Shigetoshi Murata

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24854900

Hiroaki Tanaka

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24854900

Masashi Hirooka

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24854900

Yoichi Hiasa

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24854900

Teruhito Mochizuki

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24854900

publication date

24 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24854900

Japanese journal of radiology

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24854900

32

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24854900

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24854900

405-413

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24854900

Multistep human hepatocarcinogenesis: correlation of imaging with pathology

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Relationship between signal intensity on hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MR imaging and prognosis of borderline lesions of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase.

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009).

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

A comparison of hepatopathologists' and community pathologists' review of liver biopsy specimens from patients with hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver disease.

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Hypovascular hepatic nodule showing hypointensity in the hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with chronic liver disease: prediction of malignant transformation.

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Hypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC.

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid-Enhanced Magnetic Resonance Imaging Findings of Borderline Lesions at High Risk for Progression to Hypervascular Classic Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

MRI in the evaluation of hepatocellular nodules: role of pulse sequences and contrast agents

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Early hepatocellular carcinomas showing isointensity or hyperintensity in gadoxetic acid-enhanced, hepatocyte-phase magnetic resonance images

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Cirrhotic nodules: association between MR imaging signal intensity and intranodular blood supply

1 reference

https://api.crossref.org/works/10.1007%2FS11604-014-0323-Z

21 January 2018

Detection of hypervascular malignant foci in borderline lesions of hepatocellular carcinoma: comparison of dynamic multi-detector row CT, dynamic MR imaging and superparamagnetic iron oxide-enhanced MR imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/24854900

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow

1 reference

https://pubmed.ncbi.nlm.nih.gov/24854900

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/24854900

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium

1 reference

https://pubmed.ncbi.nlm.nih.gov/24854900

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histological grade of differentiation of hepatocellular carcinoma: comparison of the efficacy of diffusion-weighted MRI with T2-weighted imaging and angiography-assisted CT

1 reference

https://pubmed.ncbi.nlm.nih.gov/24854900

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhanced MRI

1 reference

https://pubmed.ncbi.nlm.nih.gov/24854900

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/24854900

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11604-014-0323-Z

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24854900

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24854900

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53065079&oldid=2211970390"